In this study, we aimed to investigate the mutational landscape of LC and LCNEC tumors using a panel of 26 well-established oncogenes and tumor suppressor genes in combination with ALK, RET, and ROS1 gene fusion analysis and copy number analysis of targeted genes. The gene discussed is RET; the disease is large cell neuroendocrine carcinoma.